Search Results - Ирина Аркадьевна Бондарь
- Showing 1 - 2 results of 2
-
1
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial by Chantal Mathieu, Paresh Dandona, Pieter Gillard, Peter Senior, Christoph Hasslacher, Eiichi Araki, Marcus Lind, Stephen C. Bain, Serge Jabbour, Niki Arya, Lars Hansen, Fredrik Thorén, Anna Maria Langkilde, Cecilia Luquez, Federico Pérez Manghi, María Rosa Ulla, Maria Alejandra Moisello, Virginia Visco, Silvia Gorban De Lapertoza, Silvana Ernestina Solís, Javier Farias, Georgina Sposetti, Pieter Gillard, Pascale Abrams, M. van Ypersele de Strihou, James R. W. Conway, Sue D. Pedersen, Peter Senior, Joanne Liutkus, Churn-Ern Yip, Zubin Punthakee, Frédéric Bernier, Heather Lochnan, Vincent Woo, Thomas G. Elliott, Juan Palma, C Merino, A. Vargas, Ulrich Wendisch, Andreas Reichel, Jochen Seufert, Bernd Becker, Hasan Alawi, Andreas L. Birkenfeld, Christoph Hasslacher, Joerg Luedemann, Thomas Schaum, Cornelia Marck, Joachim Sauter, Ulrich Aigner, Yukiko Onishi, Hiroaki Seino, Yuichi Sato, Kiyohide Nunoi, Akira Yamauchi, Eitaro Nakashima, Hiroki Ikeda, Toshihiko Shiraiwa, Yoshimitsu Yamasaki, Hiroki Yokoyama, Kunihiko Nakamura, Masayuki Noritake, Shozo Miyauchi, Tomomi Hakoda, Yoshihide Hirohata, Atsushi Hasegawa, Yoshihide Fukumoto, Hirotaka Nagashima, Masahiro Takihata, Tetsuro Kamada, Hideaki Jinnouchi, Yuri Ono, Takayuki Watanabe, Hiroshi Ohashi, Masahiko Takai, T Seguchi, Katsuya Yamazaki, Hajime Maeda, Shingo Iwasaki, Harold W. de Valk, Adriaan Kooy, S.A.N.T. Landewé-Cleuren, Katarzyna Madziarska, Andrzej Stankiewicz, Katarzyna Wasilewska, Gottfried Rudofsky, Maciej T. Małecki, Ewa Pańkowska, Ewa Szyprowska, Monika Łukaszewicz, Lidia Tokarska, Ирина Аркадьевна Бондарь, I. V. Karpova, Ludmila Ruyatkina, Alsu Gafurovna Zalevskaya, Ruslan Sardinov, Yury Khalimov, Folke Sjöberg, Pekka Koskinen, Dan Curiac
Published 2018Artigo -
2
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicen... by Lori M. Laffel, Thomas Danne, Georgeanna J. Klingensmith, William V. Tamborlane, Steven M. Willi, Philip Zeitler, Dietmar Neubacher, Jan Marquard, Т. П. Бардымова, Margarita Barrientos Perez, Kathleen E. Bethin, Petter Bjornstad, Ирина Аркадьевна Бондарь, Mimi Chen, Jin‐Ho Choi, Mark A. Clements, Javier Ricardo Colomar, Mark Daniels, Chaicharn Deerochanawong, Vivek S Desai, Jean-Claude G Desmangles, Robert G Dillon, Naznin Dixit, Hongwei Du, Rachel Edelen, Diego Espinoza Peralta, María Verónica Felipe Gacioppo, Tânia Ferraz, Galina Galkina, Mary Patricia Gallagher, Minu George, Edgar R. Gonzalez, Michael Gottschalk, Giancarlo Guido, Amir Ali Hassan, Eli Hershkovitz, Lina Huerta‐Saenz, Jin Soon Hwang, Jaime Orlando Ibarra Gomez, Lydia Irizarry Gonzalez, Nina Jain, David H. Jelley, Ho-Seong Kim, T. A. Kovalenko, Lori M. Laffel, Steven B. Leichter, Raphael Del Roio Liberatore, Jane Lynch, Farid H. Mahmud, Oleg Arturovich Malievskiy, Andrew Muir, Bryce Nelson, Luis Alejandro Nevarez Ruiz, Micah L. Olson, Emilia Susana Pelayo Orozco, Valentina Peterkova, Fernando Ramón Ramírez Mendoza, Konda Mohan Reddy, Henry Rodriguez, Javier Andres Saenz, Julia Samoilova, Karl‐Otfried Schwab, S Shah, Naim Shehadeh, Ashley H. Shoemaker, Yulia Skorodok, Aleksandr Sobolev, Silvana Ernestina Solís, Shylaja Srinivasan, William V. Tamborlane, Eva Tsalikian, Ф. В. Валеева, Carl D Vance, Pedro Velasquez‐Mieyer, R. Ortiz, Olga Votyakova, Haiyan Wei, Ruth S. Weinstock, Mark D. Wheeler, Brandy Wicklow, Steven M. Willi, Kupper A. Wintergerst, Risa M. Wolf, Jamie Wood, Chandan Yaliwal, Hernán Yupanqui Lozno
Published 2023Artigo
Search Tools:
Related Subjects
Alternative medicine
Diabetes mellitus
Endocrinology
Insulin
Internal medicine
Medicine
Pathology
Placebo
Randomized controlled trial
Type 2 diabetes
Adverse effect
Clinical endpoint
Dapagliflozin
Diabetic ketoacidosis
Empagliflozin
Gastroenterology
Glycemic
Hypoglycemia
Linagliptin
Metformin
Regimen
Type 1 diabetes
Urology